Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emilia Titelman"'
Autor:
Linus Sandegren, Öjar Melefors, Fredrika Rajer, Emilia Titelman, Christian G. Giske, Alma Brolund
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Extended-spectrum β-lactamase-producing Enterobacteriaceae (EPE) are a major cause of bloodstream infections, and the colonization rate of EPE in the gut microbiota of individuals lacking prior hospitalization or comorbidities is increasing. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee676f6cb8011e76f23a4a988c7ab39b
https://doi.org/10.1128/aac.02201-18
https://doi.org/10.1128/aac.02201-18
Publikováno v:
APMIS. 119:853-863
Activity of oral and parenteral antimicrobials against consecutively isolated extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (n = 149) and Klebsiella pneumoniae (n = 20) was determined, and susceptibility test methods were compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b90410a6c656763688d62a5b12ca50d
https://doi.org/10.1111/j.1600-0463.2011.02766.x
https://doi.org/10.1111/j.1600-0463.2011.02766.x
Autor:
Christian G. Giske, Mats Kalin, Emilia Titelman, Aina Iversen, C.M. Hasan, Pontus Naucler, M. Kais
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 20(8)
We aimed to determine the duration of faecal carriage of extended-spectrum β -lactamase (ESBL) -producing Enterobacteriaceae (EPE) in patients with clinical infection caused by an EPE, to study host strains during carriage, and to identify factors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af58aefc17abfbcbf3b365819a5d207d
https://pubmed.ncbi.nlm.nih.gov/24450760
https://pubmed.ncbi.nlm.nih.gov/24450760
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.). 18(2)
To evaluate the clinical and bacteriological efficacy of pivmecillinam against lower urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae, patients treated for lower UTI wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d5931140bad9e686f6568f55e68161
https://pubmed.ncbi.nlm.nih.gov/22204597
https://pubmed.ncbi.nlm.nih.gov/22204597
Publikováno v:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 119(12)
Activity of oral and parenteral antimicrobials against consecutively isolated extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (n = 149) and Klebsiella pneumoniae (n = 20) was determined, and susceptibility test methods were compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc94c16895ee8be877f067ab2023819d
https://pubmed.ncbi.nlm.nih.gov/22085361
https://pubmed.ncbi.nlm.nih.gov/22085361
Publikováno v:
Diagnostic microbiology and infectious disease. 70(1)
CXA-101, a novel cephalosporin with good antipseudomonal activity, was evaluated against a consecutive and polyclonal collection of extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli (n = 149) and Klebsiella pneumoniae (n = 20), mainly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726d5a9aa1caf7f131d0820f6311656d
https://pubmed.ncbi.nlm.nih.gov/21513849
https://pubmed.ncbi.nlm.nih.gov/21513849